Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Machine Learning with Applications|July 28, 2025
Benchmarking Transformer Embedding Models for Biomedical Terminology StandardizationAditya Lahiri, Sangeeta Shukla, Ben Stear, et al.Case Reports in Oncological Medicine|January 25, 2020
Acute Myeloid Leukemia Presenting as Myeloid Sarcoma with a Predisposition to the Gynecologic TractRyan M Kahn, Sushmita Gordhandas, Eloise Chapman-Davis, et al.Oncotarget|December 22, 2017
Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progressionKseniya Petrova-Drus, April Chiu, Elizabeth Margolskee, et al.Journal of Clinical Pathology|November 8, 2023
Optimal carcinoembryonic antigen (CEA) cutoff values in the diagnosis of neoplastic mucinous pancreatic cysts differ among assaysDavid Kim, Elizabeth Margolskee, Abha Goyal, et al.Cancer Cytopathology|January 8, 2015
Strategies for improving diagnostic accuracy of biliary stricturesMarcela Salomao, Tamas A Gonda, Elizabeth Margolskee, et al.Leukemia & Lymphoma|July 9, 2016
Clinicopathologic evaluation of cytopenic patients with isolated trisomy 8: a detailed comparison between idiopathic cytopenia of unknown significance and low-grade myelodysplastic syndromeKseniya Petrova-Drus, Robert Hasserjian, Olga Pozdnyakova, et al.Cancer Cytopathology|June 24, 2020
Interobserver variability between cytopathologists and cytotechnologists upon application and characterization of the indeterminate category in the Milan System for Reporting Salivary Gland CytopathologyKartik Viswanathan, Ami Patel, Mary Abdelsayed, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 4, 2019
Chronic lymphocytic leukemia with TP53 gene alterations: a detailed clinicopathologic analysisYen-Chun Liu, Elizabeth Margolskee, John N Allan, et al.American Journal of Clinical Pathology|September 21, 2017
Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor PrognosisElizabeth Margolskee, Robert P Hasserjian, Duane Hassane, et al.Oncotarget|May 21, 2016
Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disordersElizabeth Margolskee, Vaidehi Jobanputra, Preti Jain, et al.Pageof 3